Oxyglutamate Carrier Alleviates Cerebral Ischaemia–Reperfusion Injury by Regulating Mitochondrial Function
European Journal of Neuroscience · 2025-01 · 61 (1)
DOI: 10.1111/ejn.16659 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, online erschienen am 08.01.2025. Verfasst von Wenhao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Project of Beijing DNVA Foundation.
Abstract (Originalsprache)
Mitochondrial dysfunction has been reported to participate in the pathophysiological processes of cerebral ischaemia–reperfusion injury, which include reduced energy homeostasis, increased generation of oxidative stress species (ROS) and the release of apoptotic factors. Oxyglutamate carrier (OGC) is an important carrier protein on the inner mitochondrial membrane that can transport metabolites from the cytoplasm to the mitochondria. The role of OGC in cerebral ischaemia–reperfusion injury (I/R) remains unknown. In this study, we found that the expression of OGC was significantly upregulated after cerebral ischaemia–reperfusion injury. Inhibiting OGC with phenylsuccinic acid (PSA) increased neuronal death after oxygen–glucose deprivation/reoxygenation (OGD/R) in vitro. Mechanistically, OGC was localized in mitochondria and could facilitate the transport of glutathione from the cytoplasm to the mitochondria to reduce ROS levels and increase ATP production after OGD/R. In addition, in vivo inhibition of OGC exacerbated brain infarction, and GSH supplementation alleviated brain infarction resulting from OGC inhibition. This study revealed the role of OGC in alleviating brain damage by regulating mitochondrial GSH transport to alleviate mitochondrial function after cerebral ischaemia–reperfusion injury, which may provide a target for alleviating ischaemic brain injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Qingdao Medical College, Qingdao University, Qingdao, China.
- Department of Interventional Radiology, The People's Hospital of Rizhao, Rizhao, China.
- Institute of Neuroregeneration and Neurorehabilitation, Qingdao University, Qingdao, China.
ORCID-Profile: Wenhao Liu, Xin Liu, Min Liu, Rui Zhao, Zhiyuan Zhao, Jingrui Xiao, Dongdong Wan, Qi Wan, Rui Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Project of Beijing DNVA Foundation
Zitieren
APA
Liu, W., Liu, X., Liu, M., Zhao, R., Zhao, Z., Xiao, J., Wan, D., Wan, Q., & Xu, R. (2025). Oxyglutamate Carrier Alleviates Cerebral Ischaemia–Reperfusion Injury by Regulating Mitochondrial Function. European Journal of Neuroscience, 61(1). https://doi.org/10.1111/ejn.16659
Vancouver
Liu W, Liu X, Liu M, Zhao R, Zhao Z, Xiao J, et al. Oxyglutamate Carrier Alleviates Cerebral Ischaemia–Reperfusion Injury by Regulating Mitochondrial Function. European Journal of Neuroscience. 2025;61(1). doi:10.1111/ejn.16659
BibTeX
@article{Liu2025,
author = {Liu, Wenhao and Liu, Xin and Liu, Min and Zhao, Rui and Zhao, Zhiyuan and Xiao, Jingrui and Wan, Dongdong and Wan, Qi and Xu, Rui},
title = {Oxyglutamate Carrier Alleviates Cerebral Ischaemia–Reperfusion Injury by Regulating Mitochondrial Function},
journal = {European Journal of Neuroscience},
year = {2025},
volume = {61},
number = {1},
doi = {10.1111/ejn.16659}
}
EUVIMED